InvestSMART

Sonic Healthcare Limited (ASX: SHL) - Announcements

Current share price for SHL : $20.240 0.2 (0.98%)+

ASX company news and announcements for Sonic Healthcare Limited (SHL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Sonic Healthcare Limited (SHL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Sonic Healthcare Limited (SHL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Sonic Healthcare Limited (SHL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$10,003 Sonic Healthcare Corporate Responsibility Report 2017 18 Sep 2017 4:59PM $21.370 $20.240 fallen by 5.29%
$10,003 Ceasing to be a substantial holder from MQG 15 Sep 2017 12:07PM $21.020 $20.240 fallen by 3.71%
$10,003 Dividend Reinvestment Plan Participation Rate 15 Sep 2017 11:48AM $20.960 $20.240 fallen by 3.44%
$10,003 Becoming a substantial holder from MQG 14 Sep 2017 5:23PM $20.920 $20.240 fallen by 3.25%
$10,003 Change of Director's Interest Notice 14 Sep 2017 4:06PM $20.920 $20.240 fallen by 3.25%
$10,003 Change of Director's Interest Notice 14 Sep 2017 4:02PM $20.920 $20.240 fallen by 3.25%
$10,003 Appendix 3B 7 Sep 2017 4:25PM $21.410 $20.240 fallen by 5.46%
$10,003 Sonic wins National Bowel Cancer Screening Contract 31 Aug 2017 4:03PM $21.900 $20.240 fallen by 7.58%
$10,003 CEO Presentation Full Year Results to 30 June 2017 16 Aug 2017 8:53AM $23.080 $20.240 fallen by 12.31%
$10,003 Media Release Full Year Results 30 June 2017 16 Aug 2017 8:44AM $23.080 $20.240 fallen by 12.31%
$10,003 Dividend/Distribution - SHL 16 Aug 2017 8:40AM $23.080 $20.240 fallen by 12.31%
$10,003 Preliminary Final Report 16 Aug 2017 8:34AM $23.080 $20.240 fallen by 12.31%
$10,003 Appendix 3B 4 Aug 2017 4:14PM $22.380 $20.240 fallen by 9.56%
$10,003 Appendix 3B 5 Jul 2017 5:15PM $23.340 $20.240 fallen by 13.28%
$10,003 Change in substantial holding 16 Jun 2017 10:51AM $24.100 $20.240 fallen by 16.02%
$10,003 Appendix 3B 8 May 2017 4:34PM $23.010 $20.240 fallen by 12.04%
$10,003 Change of Director's Interest Notice 11 Apr 2017 4:54PM $21.510 $20.240 fallen by 5.90%
$10,003 Change of Director's Interest Notice 11 Apr 2017 4:51PM $21.510 $20.240 fallen by 5.90%
$10,003 Change of Director's Interest Notice 11 Apr 2017 4:50PM $21.510 $20.240 fallen by 5.90%
$10,003 Appendix 3B 11 Apr 2017 4:28PM $21.510 $20.240 fallen by 5.90%
$10,003 Change of Director's Interest Notice 31 Mar 2017 4:22PM $22.120 $20.240 fallen by 8.50%
$10,003 Update - Dividend/Distribution - SHL 24 Mar 2017 5:56PM $21.470 $20.240 fallen by 5.73%
$10,003 Becoming a substantial holder 14 Mar 2017 8:08PM $21.370 $20.240 fallen by 5.29%
$10,003 Dividend Reinvestment Plan Participation Rate 14 Mar 2017 11:58AM $21.260 $20.240 fallen by 4.80%
$10,003 Ceasing to be a substantial holder 14 Mar 2017 8:25AM $21.310 $20.240 fallen by 5.02%

601 - 625 of 839 results

Page 25 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.